疫苗对健康成年人有效:有高质量的证据表明,健康成年人接种流感减毒活疫苗或灭活疫苗可高度有效预防感染。[61]Wilde JA, McMillan JA, Serwint J, et al. Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA. 1999;281:908-913.http://jama.jamanetwork.com/article.aspx?articleid=189023http://www.ncbi.nlm.nih.gov/pubmed/10078487?tool=bestpractice.com[62]Bridges CB, Thompson WW, Meltzer MI, et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA. 2000;284:1655-1663.http://jama.jamanetwork.com/article.aspx?articleid=193139http://www.ncbi.nlm.nih.gov/pubmed/11015795?tool=bestpractice.com[63]Nichol KL, Mendelman PM, Mallon KP, et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA. 1999;282:137-144.http://jama.jamanetwork.com/article.aspx?articleid=302147http://www.ncbi.nlm.nih.gov/pubmed/10411194?tool=bestpractice.com[64]Edwards KM, Dupont WD, Westrich MK, et al. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis. 1994;169:68-76.http://www.ncbi.nlm.nih.gov/pubmed/8277200?tool=bestpractice.com[65]Ohmit SE, Victor JC, Rotthoff JR, et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med. 2006;355:2513-2522.http://www.nejm.org/doi/full/10.1056/NEJMoa061850#t=articlehttp://www.ncbi.nlm.nih.gov/pubmed/17167134?tool=bestpractice.com
系统评价或者受试者>200名的随机对照临床试验(RCT)。
疫苗对健康成年人有效:有高质量的证据表明,健康成年人接种流感减毒活疫苗或灭活疫苗可高度有效预防感染。[61]Wilde JA, McMillan JA, Serwint J, et al. Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA. 1999;281:908-913.http://jama.jamanetwork.com/article.aspx?articleid=189023http://www.ncbi.nlm.nih.gov/pubmed/10078487?tool=bestpractice.com[62]Bridges CB, Thompson WW, Meltzer MI, et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA. 2000;284:1655-1663.http://jama.jamanetwork.com/article.aspx?articleid=193139http://www.ncbi.nlm.nih.gov/pubmed/11015795?tool=bestpractice.com[63]Nichol KL, Mendelman PM, Mallon KP, et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA. 1999;282:137-144.http://jama.jamanetwork.com/article.aspx?articleid=302147http://www.ncbi.nlm.nih.gov/pubmed/10411194?tool=bestpractice.com[64]Edwards KM, Dupont WD, Westrich MK, et al. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis. 1994;169:68-76.http://www.ncbi.nlm.nih.gov/pubmed/8277200?tool=bestpractice.com[65]Ohmit SE, Victor JC, Rotthoff JR, et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med. 2006;355:2513-2522.http://www.nejm.org/doi/full/10.1056/NEJMoa061850#t=articlehttp://www.ncbi.nlm.nih.gov/pubmed/17167134?tool=bestpractice.com
预防症状:有高质量的证据表明,口服吸入型扎那米韦在预防流感症状方面比安慰剂更有效,但不能预防流感样疾病。此外,在一项针对 29 项随机对照治疗试验的 meta 分析中,奥司他韦和扎那米韦对流感症状缓解时间的风险比分别为 1.33 和 1.30,前提是症状发作后 48 小时内开始治疗。[134]Jefferson TO, Rivetti D, Di Pietrantonj C, et al. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. 2007;(2):CD001269.http://www.ncbi.nlm.nih.gov/pubmed/17443504?tool=bestpractice.com 来自随机对照试验的证据一致支持奥司他韦和扎那米韦在治疗和预防流感方面具有临床疗效的观点。[129]Cooper NJ, Sutton AJ, Abrams KR, et al. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. BMJ. 2003;326:1235.http://www.bmj.com/content/326/7401/1235.fullhttp://www.ncbi.nlm.nih.gov/pubmed/12791735?tool=bestpractice.com
系统评价或者受试者>200名的随机对照临床试验(RCT)。
预防症状:有高质量的证据表明,口服吸入型扎那米韦在预防流感症状方面比安慰剂更有效,但不能预防流感样疾病。此外,在一项针对 29 项随机对照治疗试验的 meta 分析中,奥司他韦和扎那米韦对流感症状缓解时间的风险比分别为 1.33 和 1.30,前提是症状发作后 48 小时内开始治疗。[134]Jefferson TO, Rivetti D, Di Pietrantonj C, et al. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. 2007;(2):CD001269.http://www.ncbi.nlm.nih.gov/pubmed/17443504?tool=bestpractice.com 来自随机对照试验的证据一致支持奥司他韦和扎那米韦在治疗和预防流感方面具有临床疗效的观点。[129]Cooper NJ, Sutton AJ, Abrams KR, et al. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. BMJ. 2003;326:1235.http://www.bmj.com/content/326/7401/1235.fullhttp://www.ncbi.nlm.nih.gov/pubmed/12791735?tool=bestpractice.com
儿童诊断的关键因素:有低质量的研究显示发热和咳嗽对儿童季节性流感有预测价值。一些针对儿童的研究发现,在 5 岁至 12 岁的儿童中,同时出现发热和咳嗽症状对诊断流感的阳性预测值为 71%-83%,而此预测值在 <5 岁的儿童中为 64%。[90]Advisory Committee on Immunization Practices. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) - United States, 2013-2014. MMWR Recomm Rep. 2013;62:1-43. [Erratum in: MMWR Recomm Rep. 2013;62:906.]http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6207a1.htmhttp://www.ncbi.nlm.nih.gov/pubmed/24048214?tool=bestpractice.com 在一项大样本的监测研究中,所有发热或急性呼吸道感染的症状的患儿进行了流感测试,实验室确诊的流感病例中报告有发热,咳嗽症状,小于6个月的住院儿童为70%,6个月~5岁的住院患儿为91%。[90]Advisory Committee on Immunization Practices. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) - United States, 2013-2014. MMWR Recomm Rep. 2013;62:1-43. [Erratum in: MMWR Recomm Rep. 2013;62:906.]http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6207a1.htmhttp://www.ncbi.nlm.nih.gov/pubmed/24048214?tool=bestpractice.com
系统评价或者受试者>200名的随机对照临床试验(RCT)。
儿童诊断的关键因素:有低质量的研究显示发热和咳嗽对儿童季节性流感有预测价值。一些针对儿童的研究发现,在 5 岁至 12 岁的儿童中,同时出现发热和咳嗽症状对诊断流感的阳性预测值为 71%-83%,而此预测值在 <5 岁的儿童中为 64%。[90]Advisory Committee on Immunization Practices. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) - United States, 2013-2014. MMWR Recomm Rep. 2013;62:1-43. [Erratum in: MMWR Recomm Rep. 2013;62:906.]http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6207a1.htmhttp://www.ncbi.nlm.nih.gov/pubmed/24048214?tool=bestpractice.com 在一项大样本的监测研究中,所有发热或急性呼吸道感染的症状的患儿进行了流感测试,实验室确诊的流感病例中报告有发热,咳嗽症状,小于6个月的住院儿童为70%,6个月~5岁的住院患儿为91%。[90]Advisory Committee on Immunization Practices. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) - United States, 2013-2014. MMWR Recomm Rep. 2013;62:1-43. [Erratum in: MMWR Recomm Rep. 2013;62:906.]http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6207a1.htmhttp://www.ncbi.nlm.nih.gov/pubmed/24048214?tool=bestpractice.com